General Information of the Protein
Protein ID |
PT06019
|
||||
---|---|---|---|---|---|
Protein Name |
Potassium channel subfamily K member 3
|
||||
Secondarily Protein Name |
Acid-sensitive potassium channel protein TASK-1
TWIK-related acid-sensitive K(+) channel 1
Two pore potassium channel KT3.1
|
||||
Gene Name |
KCNK3
|
||||
Secondarily Gene Name |
TASK
TASK1
|
||||
Sequence |
MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Ion channel
>
Voltage-gated ion channel
>
Potassium channels
>
Two-pore domain potassium channel
|
||||
Function |
pH-dependent, voltage-insensitive, background potassium channel protein. Rectification direction results from potassium ion concentration on either side of the membrane. Acts as an outward rectifier when external potassium concentration is low. When external potassium concentration is high, current is inward.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Biochemical Assays
Compound ID | Compound Name | Compound Formula | |
CP0234037 |
1-[1-[6-(4-phenylbenzoyl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]piperidin-4-yl]butan-1-one
Show/Hide
|
C29H32N4O2
|
1 |
1 | IC50 = 300 nM |
---|
Clinical Information about the Protein
Target 1 ( TWIK-related acid-sensitive potassium channel 1 (TASK1) )
Target Type | Clinical trial Target |
---|